Immune Therapeutics Inc (OTCQB:IMUN)

0.07
Delayed Data
As of Jul 01
 -0.01 / -12.50%
Today’s Change
0.05
Today|||52-Week Range
0.44
-58.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization0.001.6M2.9M2.9M
 
 
 
 
 
Operating ExpensesGross Income0.00-1.6M-2.9M-2.9M
 
 
 
 
General Expenses--27.7M93.1M30.7M
 
 
 
 
Research And Development0.005.0M22.0M7.5M
 
 
 
 
Total Operating Expenses0.0029.3M96.0M33.6M
 
 
 
 
 
Non-Operating ExpensesOperating Income0.00-29.3M-96.0M-33.6M
 
 
 
 
Extraordinary Charge0.00-145.9M-8.6M-15.9M
 
 
 
 
Interest Expense On Debt31.3K27.0K1.4M388.2K
 
 
 
 
 
Other Expenses0.000.00-224.00-783.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.3K-175.2M-106.1M-49.9M
 
 
 
 
 
Minority Interest0.000.000.00-1.7M
 
 
Discontinued Operations-94.4K231.4K0.000.00
 
 
 
Net Income-125.7K-175.0M-106.1M-48.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS113.6425.6M57.2M98.5M
 
 
 
 
 
Shares To Calculate EPS Diluted113.6425.6M57.2M98.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1,110.00-$6.84-$1.85-$0.49
 
 
 
 
 
EPS Diluted-$1,110.00-$6.84-$1.85-$0.49
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account